PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton
 Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in
 patients with Non-hodgkin Lymphoma.
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton
 Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in
 patients with Non-hodgkin Lymphoma to compare the difference in efficacy.
Inclusion Criteria:

 -  DLBCL Lymphoma subtype --No comorbid disease

 Exclusion Criteria:

 -  Pregnancy

 -  Peptic ulcer

 -  Severe cardiac disease

 -  Osteoporosis